Related Experiment Video
Updated: Aug 19, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
Epigenetically suppressed tumor cell intrinsic STING promotes tumor immune escape
Hui Zheng1, Lizhen Wu2, Qian Xiao3
1Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.
Abstract:
DNA sensing through the cGAS-STING pathway plays an important role in cancer immunosurveillance. Pharmaceutical activation of STING in the tumor environment is considered an attractive approach to induce anti-tumor immunity, but had limited efficacy in the clinic. Several studies have found that STING is epigenetically silenced in many tumors, including colon cancer. This suggests that STING silencing in tumor cells contributes to immune escape and may limit the application of STING agonists. We previously found that inhibition of the KDM5 family histone demethylases restored STING expression in human breast cancer cells and activated the cGAS-STING pathway. In this study, we used MC38 and CT26 syngeneic mouse colorectal cancer models to show that loss of STING in tumor cells accelerates tumor growth. KDM5 inhibitors activate STING expression in mouse colorectal cancer cells and suppress colon cancer growth in immune competent mice in a STING-dependent manner. This study highlights KDM5 inhibitors as novel immune modulators in cancer therapies.
Insights
KDM5 inhibitors restore STING expression in colon cancer cells, suppressing tumor growth. This research reveals KDM5 inhibitors as potential immune modulators for cancer therapy by reactivating the cGAS-STING pathway.
Area of Science:
- Immunology
- Cancer Biology
- Epigenetics
Background:
- The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for cancer immunosurveillance.
- Pharmaceutical activation of STING shows promise for anti-tumor immunity but faces clinical limitations.
- Epigenetic silencing of STING in tumors, including colon cancer, contributes to immune escape.
Purpose of the Study:
- To investigate the role of STING in colorectal cancer growth.
- To evaluate the efficacy of KDM5 inhibitors in restoring STING expression and function in colon cancer models.
- To explore KDM5 inhibitors as novel cancer therapeutics.
Main Methods:
- Utilized MC38 and CT26 syngeneic mouse colorectal cancer models.
- Assessed the impact of STING loss on tumor progression.
- Administered KDM5 inhibitors to evaluate their effect on STING expression and tumor growth in immune-competent mice.
Main Results:
- Loss of STING in tumor cells accelerated colorectal cancer growth.
- KDM5 inhibitors successfully reactivated STING expression in mouse colon cancer cells.
- KDM5 inhibitors suppressed colon cancer growth in a STING-dependent manner in vivo.
Conclusions:
- STING plays a critical role in suppressing colon cancer progression.
- KDM5 inhibitors can overcome STING silencing, thereby enhancing anti-tumor immunity.
- KDM5 inhibitors represent a promising new class of immune modulators for cancer treatment.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Related Concept Videos
Tumor Immunotherapy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Tumor Microenvironment
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...